Respiratory Inhalers Market

Respiratory Inhalers Market

According to our new research study on "Respiratory Inhalers Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product Type, Technology, and Disease Indication," the market is expected to grow from US$ 31,144.56 million in 2022 to US$ 43,446.19 million by 2028; it is estimated to record a CAGR of 5.7% from 2022 to 2028. The report highlights the trends and drivers prevailing in the market.

Get PDF Sample Report + All Related Table and Graphs @:

Based on product type, the respiratory inhalers market is segmented nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment is further bifurcated into multi-dose dry powder inhalers and single-dose dry powder inhalers. The metered dose inhalers (MDI) segment is further divided into pressured metered dose inhalers and connected metered dose inhalers. The nebulizers segment is subsegmented into compressed air nebulizers, mesh air nebulizers, and ultrasonic air nebulizers. In 2022, the dry powder inhalers segment accounted for the largest market share.

The report shows the latest market insights, current situation analysis with upcoming trends, and breakdown of the products and services. It then provides a detailed overview of the factors influencing the global business scope. The global Respiratory Inhalers market has been segmented on the basis of technology, product type, application, distribution channel, end-user, and geography, delivering valuable insights. The report identifies various key manufacturers in the market.

Competitive Landscape: Respiratory Inhalers Market: AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd.; GSK Plc; Koninklijke Philips NV; OMRON Corp; PARI Respiratory Equipment, Inc.; Teva Pharmaceutical Industries Ltd.; and OPKO Health, Inc. are among the several players engaged in addressing the growing demands for respiratory inhalers.

Based on technology, the respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger market share in 2022 and is expected to register a higher CAGR during the forecast period.

The research on the Respiratory Inhalers market focuses on mining out valuable data on investment pockets, growth opportunities, and major market vendors to help clients understand their competitor's methodologies. The research also segments the Respiratory Inhalers market on the basis of end user, product type, application, and demography for the forecast period to 2028. Comprehensive analysis of critical aspects such as impacting factors and competitive landscape are showcased with the help of vital resources, such as charts, tables, and infographics.

Inquire before Buying Copy of Respiratory Inhalers Market:

Based on disease indication, the respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the market in 2022 and is expected to grow at the highest CAGR during the forecast period. Asthma is a respiratory condition in which the patient's airway swells and becomes narrow and sometimes produces extra mucus. This makes breathing difficult and triggers coughing. It is a long-term condition and noncommunicable disease affecting children and adults. Asthma is often underdiagnosed and under-treated, particularly in low- and middle-income countries. People suffering from under-treated asthma also experience sleep disturbance, tiredness during the day, and poor concentration. Asthma cannot be cured, but good management with inhaled medications can control the disease and enable people with asthma to enjoy a normal, active life. According to the Global Asthma Report New Zealand 2018, globally, asthma is ranked 16th among the leading causes of years lived with disability and 28th among the leading causes of burden of disease, as measured by disability-adjusted life years.

Impact of COVID-19 Pandemic on Respiratory Inhalers Market
The rising number of COVID-19 patients led to an overall positively impacted on the respiratory inhalers market. COVID-19 is a respiratory system infection that can rapidly cause pneumonia-like symptoms and chest infections. This may lead to poor health conditions for the patient. During the COVID-19 pandemic, respiratory inhaler providers were encouraged to increase manufacturing as COVID-19 affects the functioning of the lungs. Inhaled corticosteroids are beneficial in the treatment of COVID-19, as they reduce the expression of key proteins that are involved in the entry of SARS-CoV-2 into host cells. Inhaled corticosteroids have also been shown to cause the downregulation of COVID-19 genes. For instance, ciclesonide is a potential treatment option for COVID-19 patients.

This research provides detailed information regarding the major factors influencing the growth of the Respiratory Inhalers Market in Global and Regional Level (drivers, restraints, opportunities, and challenges), forecast of the market size, in terms of value, market share by region and segment; regional market positions; segment and country opportunities for growth; New product developments, strengths and weaknesses, brand portfolio; Marketing and distribution strategies; challenges and threats from current competition and prospects; Key company profiles, SWOT, product portfolio and growth strategies.

The research provides answers to the following key questions:
1. What is the estimated growth rate of the market for the forecast period to 2028? What will be the market size during the estimated period?
2. What are the key driving forces responsible for shaping the fate of the Respiratory Inhalers market during the forecast period?
3. Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the Respiratory Inhalers market?
4. What are the prominent market trends influencing the development of the Respiratory Inhalers market across different regions?
5. What are the major threats and challenges likely to act as a barrier in the growth of the Respiratory Inhalers market?
6. What are the major opportunities the market leaders can rely on to gain success and profitability?

Interested in Purchasing this Report? Click here @

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare, Manufacturing and Construction, Media and Technology, Chemicals, and Materials.

This release was published on openPR.

Source link